![The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma | Scientific Reports The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-63816-9/MediaObjects/41598_2020_63816_Fig1_HTML.png)
The number of metabolic features as a significant prognostic factor in patients with metastatic renal cell carcinoma | Scientific Reports
![Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma](https://www.frontiersin.org/files/MyHome%20Article%20Library/473816/473816_Thumb_400.jpg)
Frontiers | Retrospective Multicenter Long-Term Follow-up Analysis of Prognostic Risk Factors for Recurrence-Free, Metastasis-Free, Cancer-Specific, and Overall Survival After Curative Nephrectomy in Non-metastatic Renal Cell Carcinoma
![Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-019-49250-6/MediaObjects/41598_2019_49250_Fig2_HTML.png)
Validation of the GRade, Age, Nodes and Tumor (GRANT) score within the Surveillance Epidemiology and End Results (SEER) database: A new tool to predict survival in surgically treated renal cell carcinoma patients
![Kaplan-Meier survival analyses of patients with metastatic renal cell... | Download Scientific Diagram Kaplan-Meier survival analyses of patients with metastatic renal cell... | Download Scientific Diagram](https://www.researchgate.net/publication/304249872/figure/fig1/AS:560774998433793@1510710586837/Kaplan-Meier-survival-analyses-of-patients-with-metastatic-renal-cell-carcinoma-treated.png)
Kaplan-Meier survival analyses of patients with metastatic renal cell... | Download Scientific Diagram
![Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival - European Urology Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/c13539ab-0277-4429-bb72-b18d3730bbca/gr1.jpg)
Renal Cell Carcinoma in Adults 40 Years Old or Less: Young Age is an Independent Prognostic Factor for Cancer-Specific Survival - European Urology
![Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - ScienceDirect Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0923753419353566-gr1.jpg)
Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry - ScienceDirect
![Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5900-1/MediaObjects/12885_2019_5900_Fig4_HTML.png)
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text
![Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-022-01694-6/MediaObjects/41591_2022_1694_Fig1_HTML.png)
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial | Nature Medicine
![Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5900-1/MediaObjects/12885_2019_5900_Fig3_HTML.png)
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text
![Frontiers | Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study Frontiers | Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study](https://www.frontiersin.org/files/Articles/604724/fonc-11-604724-HTML/image_m/fonc-11-604724-g001.jpg)
Frontiers | Cause-Specific Mortality Among Survivors From T1N0M0 Renal Cell Carcinoma: A Registry-Based Cohort Study
![Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-5900-1/MediaObjects/12885_2019_5900_Fig1_HTML.png)
Survival of patients receiving systematic therapy for metachronous or synchronous metastatic renal cell carcinoma: a retrospective analysis | BMC Cancer | Full Text
![The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12885-019-6311-z/MediaObjects/12885_2019_6311_Fig3_HTML.png)
The Clinicopathological features and survival outcomes of patients with different metastatic sites in stage IV breast cancer | BMC Cancer | Full Text
![Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram](https://www.researchgate.net/profile/Jun-Teishima/publication/263702696/figure/fig2/AS:667619061411855@1536184196912/Overall-survival-curves-for-A-all-140-patients-with-metastatic-renal-cell-carcinoma-and.png)
Overall survival curves for (A) all 140 patients with metastatic renal... | Download Scientific Diagram
![Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab - Clinical Genitourinary Cancer Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab - Clinical Genitourinary Cancer](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/1e25e3a3-afcb-4c97-a629-b0987a81fd2d/gr1.jpg)
Modified Glasgow Prognostic Score as a Predictor of Prognosis in Metastatic Renal Cell Carcinoma Treated With Nivolumab - Clinical Genitourinary Cancer
![Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram](https://www.researchgate.net/publication/301480827/figure/fig1/AS:485970496757760@1492875803905/Overall-survival-of-180-patients-with-metastatic-renal-cell-carcinoma-treated-with-IFN-a.png)
Overall survival of 180 patients with metastatic renal cell carcinoma... | Download Scientific Diagram
![Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology](https://www.annalsofoncology.org/cms/asset/684b750a-03b5-4494-b310-768504324d01/gr1.jpg)
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
![Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib - Clinical Genitourinary Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib - Clinical Genitourinary](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/04f3cd1a-7ada-455e-84a4-4f0f15bcbde5/gr1_lrg.jpg)
Primary Tumor Shrinkage and the Effect on Metastatic Disease and Outcomes in Patients With Advanced Kidney Cancer With Intermediate or Poor Prognosis Treated With Nivolumab Plus Ipilimumab or Cabozantinib - Clinical Genitourinary
![Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram Overall survival for patients with progressive metastatic renal cell... | Download Scientific Diagram](https://www.researchgate.net/publication/7781128/figure/fig2/AS:601588360032308@1520441250678/Overall-survival-for-patients-with-progressive-metastatic-renal-cell-carcinoma-treated.png)